These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 6239790)

  • 1. Adrenergic activity as a modulating factor in the genesis of myocardial hypertrophy in the rat.
    Genovese A; Chiariello M; Bozzaotre M; Latte S; De Alfieri W; Condorelli M
    Exp Mol Pathol; 1984 Dec; 41(3):390-6. PubMed ID: 6239790
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiac hypertrophy in the absence of pressure overload: an experimental and clinical report.
    Genovese A; Latte S; Betocchi S; Bozzaotre M; Giunta A; Chiariello M
    Clin Exp Pharmacol Physiol; 1984; 11(1):91-5. PubMed ID: 6232026
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vivo cardiovascular responses to isoproterenol, dopamine and tyramine after prolonged infusion of isoproterenol.
    Hayes JS; Pollock GD; Fuller RW
    J Pharmacol Exp Ther; 1984 Dec; 231(3):633-9. PubMed ID: 6094797
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Catecholamine-induced necrosis and hypertrophy. Hemodynamic factors.
    Middleton KM; Henderson AH; Lewis MJ
    Adv Myocardiol; 1985; 6():339-48. PubMed ID: 3158047
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of isoproterenol-induced cardiac hypertrophy.
    Taylor PB; Tang Q
    Can J Physiol Pharmacol; 1984 Apr; 62(4):384-9. PubMed ID: 6203632
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rat strain-related differences in myocardial adrenergic tone and the impact on cardiac fibrosis, adrenergic responsiveness and myocardial structure and function.
    Osadchii O; Norton G; Deftereos D; Woodiwiss A
    Pharmacol Res; 2007 Apr; 55(4):287-94. PubMed ID: 17257851
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Isoproterenol sensitivity of isolated cardiac myocytes from rats with monocrotaline-induced right-sided hypertrophy and heart failure.
    Vescovo G; Jones SM; Harding SE; Poole-Wilson PA
    J Mol Cell Cardiol; 1989 Oct; 21(10):1047-61. PubMed ID: 2555526
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of sodium houttuyfonate on myocardial hypertrophy in mice and rats.
    Gao JP; Chen CX; Wang Y; Lü J; Gu WL
    J Pharm Pharmacol; 2009 May; 61(5):677-83. PubMed ID: 19406008
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bbeta-adrenergic receptor kinase-1 levels in catecholamine-induced myocardial hypertrophy: regulation by beta- but not alpha1-adrenergic stimulation.
    Iaccarino G; Dolber PC; Lefkowitz RJ; Koch WJ
    Hypertension; 1999 Jan; 33(1 Pt 2):396-401. PubMed ID: 9931136
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of pressure overload, left ventricular hypertrophy on beta-adrenergic receptors, and responsiveness to catecholamines.
    Vatner DE; Homcy CJ; Sit SP; Manders WT; Vatner SF
    J Clin Invest; 1984 May; 73(5):1473-82. PubMed ID: 6325505
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiac beta-adrenergic signaling pathway alteration in isoproterenol-induced cardiac hypertrophy in male Sprague-Dawley rats.
    Hakamata N; Hamada H; Ohsuzu F; Nakamura H
    Jpn Heart J; 1997 Nov; 38(6):849-57. PubMed ID: 9486938
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Angiotensin II maintains, but does not mediate, isoproterenol-induced cardiac hypertrophy in rats.
    Golomb E; Abassi ZA; Cuda G; Stylianou M; Panchal VR; Trachewsky D; Keiser HR
    Am J Physiol; 1994 Oct; 267(4 Pt 2):H1496-506. PubMed ID: 7524366
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Catecholamine-induced cardiac hypertrophy in a denervated, hemodynamically non-stressed heart transplant.
    Larson DF; Copeland JG; Russell DH
    Life Sci; 1985 Jul; 36(26):2477-89. PubMed ID: 3159947
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of captopril on isoproterenol-induced cardiac hypertrophy and polyamine contents.
    Shimizu M; Sasaki H; Sanjo J; Ogawa K; Mizokami T; Yagi T; Kato H; Hamaya K; Namiki A; Isogai Y
    Jpn Circ J; 1992 Nov; 56(11):1130-7. PubMed ID: 1453538
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regression of isoproterenol-induced cardiac hypertrophy.
    Tang Q; Taylor PB
    Can J Physiol Pharmacol; 1984 Sep; 62(9):1141-6. PubMed ID: 6208988
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of pharmacodynamics between carvedilol and metoprolol in rats with isoproterenol-induced cardiac hypertrophy: effects of carvedilol enantiomers.
    Hanada K; Asari K; Saito M; Kawana J; Mita M; Ogata H
    Eur J Pharmacol; 2008 Jul; 589(1-3):194-200. PubMed ID: 18534575
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Catecholamine-induced cardiac hypertrophy: significance of proto-oncogene expression.
    Zimmer HG
    J Mol Med (Berl); 1997; 75(11-12):849-59. PubMed ID: 9428617
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Studies on isoproterenol-induced cardiomegaly in rats.
    Stanton HC; Brenner G; Mayfield ED
    Am Heart J; 1969 Jan; 77(1):72-80. PubMed ID: 4235985
    [No Abstract]   [Full Text] [Related]  

  • 19. Basal muscarinic activity does not impede beta-adrenergic activation in rabbit hearts in controls or thyroxine-induced cardiac hypertrophy.
    Naim KL; Rabindranauth P; Scholz PM; Tse J; Weiss HR
    J Cardiovasc Pharmacol; 1997 Oct; 30(4):405-11. PubMed ID: 9335397
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The myocardial beta-adrenergic system in spontaneously hypertensive heart failure (SHHF) rats.
    Anderson KM; Eckhart AD; Willette RN; Koch WJ
    Hypertension; 1999 Jan; 33(1 Pt 2):402-7. PubMed ID: 9931137
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.